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Summary: A study is described on the Standardization of the determination of neonatal total bilirubin. A
wide Variation in results was shown in surveys held in The Netherlands and Germany and the reasons for
this Variation were sought. The suitability of commercial bilirubin Standards and direct reading Instruments,
widely used in the neonatal field, was tested by comparing all measurements with those obtained with the
candidate reference method. We found differences between the stated^values and those obtained by the
reference method. However, a bias was also shown to exist between the results measured with the direct
reading Instruments and those obtained with the reference method, explaining at least qualitively, the
Variation seen in the surveys. In addition, problems in the calibration of the DuPont ACA are discussed.
Introduction
In previous articles we described our concern with
the accuracy and the precisipn of the determination
of the concentration of total bilirubin in neonatal
serum (l, 2). For a number of reasons we decided to
study in detail various analytical aspects of commonly
used techniques. A very impqrtant reason is the avail-
ability now of the recently published candidate refer-
ence method for total bilirubin (3). It should be
possible to study the state of the art in the neonatal
field against the background of this technique.
Tab. l. Information conceraing the state of the art of the deter-
mination of neonatal bilirubin (total) in The Nether-
lands.
a. Methods in use
1. diazq methods 38%
2. direct spectrometric methods with dilütion 33%
3. direct spectrometric methods without dilütion 25%
b. Calibration
1. commercial Standards 46%
2. own Standards 2%
3. factor 30%
4. factor H- Standards 7%
5. Hertz method 4%
6. filter 2%
In addition, we were involved in discussions on the
results of surveys held in The Netherlands and the
Federal Republic of Germany. The surveys indicate
a high coefficient of Variation mainly due to a lack
of valid Standardization (CV's 8-10%). Finally, we
wanted to re-evaluate our own calibration procedure
for our DuPont ACA-NBIL method, which is a
bichromatic method with buffer dilütion (4).
The starting point of the study was the questionnaire
on neonatal bilirubin which was included in a survey
organized by the Dutch Foundation for Quality As-
sessment in Clinical Chemistry in February 1986. The
most relevant practical Information is given in table l.
The Information given in table l led us to question the
validity of the various Standardization procedures.
Materials and Methods
Materials
The neonatal serum samples were from babies up to one week
old. The samples were pooled to obtain a sufficient quantity
for the study. The various specimens were collected over a
period of two weeks, during which time they were stored at
-20 °C.
The adult serum samples (not pooled) were chosen at random.
Some of these were known to have an elevated conjugated
bilirubin level.
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The bilirubin for our own Standards was from Pfanstiehl (Refer-
ence Grade). The purity was checked and compared with SRM
916 from the National Bureau of Standards by the Dutch
National Institute of Public Health (5).
Human albumin, purified, ORHA 20/21 was from Behring-
werke AG. The bilirubin Standards in human serum and in
human albumin were prepared exactly according to the instruc-
tions described by Doumas et al. (3).
The following commercial preparations were used.
1. Dade Bilirubin-Control, lot No. BIG 972. A human albu-
min-based control material.
2. Boehringer Mannheim Precibil, lot No. 1-211. A human
serum-based control material.
3. Beckman Ultimate Bilirubin Calibrators C4, C8 and C20,
lot Nos. C 506056, C 506057 and C 506055 resp. Three
human serum-based control materials.
4. DuPont ACA Liquid Bilirubin Calibrators, lot No. 011251.
Three bovine serum-based materials intended for calibrating
the ACA.
5. Control materials from the Dutch National Institute of
Public Health·. These bovine serum-based materials were
validated according to a value assignment programme with
8 participants using the candidate reference method (11).
Methods
The candidate reference method for the determination of total
bilirubin was applied for all serum samples: neonatal, adult
and commercial s well s for the Standard preparations (3).
The control materials issued by the Dutch National Institute
of Public Health (5) (see above) served s a check on the whole
procedure.
Spectrophotometers were checked s described by Perry et al.,
i.e. wavelength calibration with a holmium oxide glass filter,
photometric accuracy with potassium dichromate Solutions and
photometric linearity with cobaltous ammonium sulphate solu-
tions (6).
The Hertz method, which is a bichromatic measurement with
buffer dilution, was applied s published by Hertz, Dybkaer &
Lauritzen (7), using the formula:
CK, = f (21.6 χ A466 - 27.4 χ Α522),
where
cbi, represents the concentration of total bilirubin in μηιοΐ/ΐ and
f the dilution factor.
The direct reading bilirubin determinations were carried out
with plane Hellma micro-cuvets equipped with a small glass
plate which can be dipped into the cuvets leaving an optical
path length of 0.87 mm.
The DuPont ACA-NBIL was used according to the instruction
of the manufacturer except for the calibration procedure (see
Results and Discussion).
Terminology
Direct reading in this study means that the absorbance of the
sample is measured without dilution.
Results
Because of the widespread popularity of commercial
preparations, at least in The Netherlands, we started
the study by checking the analytical data provided in
the Information sheets of the commercial products
mentioned under Materials and Methods. This was
done on three different days in triplicate using two
methods i.e. the candidate reference method and
the method of Hertz et al. We used only human
preparations. We also analysed our own Standards
prepared with human albumin and in human serum.
In table 2 all Standard data are given, measured a.s
well s stated.
With the data mentioned in table 2 we were ble to
calculate the accuracy of the neonatal serum determi-
nations for a direct reading measurement. Direct
reading Instruments are b sed on a bichromatic
measuring principle and are very popul r in the neo*
natal field. Mostly the light absorption of the sample
(serum) is measured directly at two wavelengths i. e.
ne for bilirubin and the other for correctipn for
haemogl bin. We simulated this Situation with our
spectrophotometer by measuring absorbance at the
commonly used wavelength c mbinations 461 — 551
nm and 455 — 575 nm. The following formula (or its




Tab. 2. Vahies for Standard bilirubin preparations.
Only diazo results are mentioned for commercial sera.
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Table 3 shows the results of the ealculations based
on the absorbance measurements of the neonatal
samples s well s the various bilirubin Standards.
The bilirubin data thus obtained can be compared
with those obtained by applying the candidate refer-
ence method. For convenience the table shows the
average deviations, calculated s a percentage, be-
tween the direct reading method results and the refer-
ence method results. Only the results for the combina-
tion 461 —551 nm have been used, but similar results
were found with the combination 455 — 575 nm.
Tab. 3. Comparison of direct measurement technique with ref-
erence method.
Absorbance readings of 16 neonatal sera (r nge:
130 — 218 μιηοΐ/ΐ) and bilirubin preparations were taken





a. Average reference method values for 16 neonatal
sera.
b. Average ealculations based on diazo values for bili-
rubin preparations found with the reference method.
Here cstandard represents the value found with the
reference method for the various bilirubin prepara-
tions.
c. Average ealculations based on diazo values for bili-
rubin preparations given by the manufacturer. Here
^Standard represents the value given in the insert.
d. Percentage difference between a. and b.



































Finally we considered the ealibration of the DuPont
ACA. This machine reads absorbance at 452 and
540 nm after dilution with buffer and calculates the
results n the basis of stored ealibration data. We
routinely calibrate with serum samples from adult
patients (sufficient sample volume!). Samples with
elevated bilirubin levels are measured with the Hertz
technique,. which is easily applicable, and the results
are used s set points for the ACA. This approach
m y seem ambiguous because it combines c libration
with sera from adults with measurement of sera from
neonates. However, it is o r experience that the neon-
atal results thus obtained with the ACA correlate
very well with those from our own diazo method. We
therefore wanted to check for a similar correlation
with the reference method. The results of 20 neonatal
samples are given in figure 1. The average ACA va-
lues proved to be 164 μιηοΐ/ΐ while the average refer-
ence method values were 167 μιηοΐ/l. As a comparison
we also measured these samples with the Hertz
method, giving an average value of 180 μηιοΐ/ΐ. Fig-
ure 2 shows the data from 25 adult serum samples
handled at the same way, i. e. ACA and Hertz, to-
gether with data from the above-mentioned neonatal
samples. A comparable graph can be constructed
with the reference method results on the y-axis i. e.
we found a difference between adult and neonatal
samples when applying the Hertz method. In other
w rds, the Hertz method cannot be used s a ealibra-
tion method for neonatal bilirubin. This surprising
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Fig. l. Comparison of results obtained with the neonatal sera







Fig. 2. Comparison of results obtained with the Hertz method
and the ACA-NBIL, using neonatal (o —o) and adult
(X-X) sera.
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The final part of the study concerned with application
of the commercial serum samples mentioned above
and the liquid bilirubin calibrators issued by DuPont.
Table4 shows the differences between the various
diazo values and the ACA results, calibrated s
shown in figure l and 2.
Tab. 4. Coraparison of ACA bilirubin values (NBIL), reference
method values and stated values.
Only diazo results are mentioned except for Dade Bili-
rubin Control. Calibration of ACA: see text.
a. b. c. d.
Stated Reference ACA Differ-
value method value ence
found found a—c





















































*) After completion of the work and the manuscript, the manu-
facturer reassigned these values, which are now 22, 139 and
291 μιηοΐ/ΐ resp. This would result in differences (a-c) of
9, < l and 2% resp.
Discussion
From the tables and figures it is clear that a uniform
solution for the Standardization of various neonatal
bilirubin methodologies is very difficult to achieve.
At least we can better understand now why there
is so much Variation with respect to accuracy and
precision s shown by the surveys held in The Nether-
lands and Germany.
It is certainly valuable that candidate reference meth-
od exists for the determination of total bilirubin in
serum. Because of the reasons mentioned by Doumas
et al. a diazo procedure (3) was chosen. There is no
reason to ignore the application of this technique in
the neonatal field, although direct reading methods
are very popul r for neonatal analysis. The same
holds true for bichromatic measurements with buffer
dilution. It is understandable that commercial Stand-
ard serum samples are used for these methods (tab.
1). However, s already mentioned, surveys point to
a wide Variation in bilirubin results.
Most of the commercial Standards r(often called con-
trol sera with assayed values have a quoted diazo
value with a certain r nge, the origin of which is
very difficult to trace for the user. Therefore, it was
worthwhile in our opinion to apply the "officially
proposed" diazo method for these products. As can
be seen from table 2 we found some differences be-
tween our reference method values and the values
given by the manufacturer. We do not know whether
these differences can be attributed to the lots we used
in this study or to the diazo modification. In addition
to the checks described u der Materials and Methods
we also determined the vsirious bilirubin preparations
with the Hertz technique; the values obtaiiied with
this method correlate well with the quoted values for
the commercial products used by Hertz et al. in their
study (7).
However, the reported differences mean that for di-
rect reading, s described in table 3, the results of the
actual neonatal bilirubin determinations can show a
wide Variation. In a clinical Situation this could mean
that one hospital would take no special c re, while
another hospital would consider phototherapy or
even exchange transfusion on the basis of the labor -
tory results. This is of course an unacceptable Situa-
tion.
The question arises of how the candidate reference
method can be applied in the neonatal field. There is
no doubt that a correct calibration is Valuable in
improving the accuracy (l, 2, 10). The same holds
true for the application of the candidate reference
method. The problem, however, is that the neonatal
serum matrix differs in certain aspects from the adult
serum matrix (protein composition, carotenoids).
These differenees may play a role when dealiiig with
bichromatic measurements, so one has to consider
the prod ction of an "ideal" bilirubin Standard pre-
paration with neonatal serum. This seems to us a
very difficult approach. Therefore the solution must
be either more imperative or more pragmatic. Imper-
ative by "banning" direct reading Instruments or at
least promoting the diazo procedure. Pragmatic, be-
ing the most elegant solution for the time being,
by following the National Committee for Clinical
Laboratory Standards (NCCLS) recdmmendations
which implies the application of the Prineipal Assign-
ed Value (PAV) and the System Specific Value (SSV)
concept. This is already done -by the Dade comp riy
in the neonatal field. The produpt sheet of the Dade
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Bilirubin Control contains data for the various biliru-
bin methodologies. Use of the target value given for
the direct reading method and recalculation of the
neonatal serum results gives a considerable improve-
ment; instead of a difference of 30% between the
reference and direct measurement values (tab. 3),
the difference is now 16% (not given in the table).
Although this is an improvement, the Situation is still
not entirely satisfactory, because the product data
are difficult to trace for the general user. However,
in the absence of official recommendations, the man-
ufacturer has to select his own policy.
Table 3 gives the impressipii that for direct reading
measurements human serum is a better protein matrix
than human albumin, notwithstanding the shortcom-
ings mentioned before. This Impression is based on
the results obtained with the Dade Bilirubin-Control
and our own albumin preparation.
The last part of the study concerned the calibration
of the DuPont ACA. As explained above (see Results
and fig. l and 2) we have a satisfactory calibration
procedure for our own purpose. Expressed simply, we
take the "wrong" (i. e. adult) samples for calibration,
measure these with the well established Hertz method
(for which we found a matrix effect, see fig. 2) and
the result gives the right answer for neonatal samples
äs judged on the application of the reference method
(fig. 1). Also with the calibration of the ACA we meet
a problematic Situation when consideriüg commercial
and home-made bilirubin preparations äs can be seen
in table 4. In this connection, it is remarkable that
we found the largest deviations for the calibrating
materials that were specially developed for use in the
ACA (see addendum).
At the moment we have no answer to this problem
except the above mentioned NCCLS-concept or our
own procedure. Maybe we are concerned here with
a matrix effect for which Vink et al. have proposed
an interesting and promising solution (8). Work is in
progress now in trying to find a satisfactory explana-
tion and solution for the Standardization of neonatal
bilirubin measurements.
Since direct reading Instruments are simple to operate
and look like push-button machines, the question
may arise äs to whether it is acceptable to use them
on wards without control from the central laboratory
(9). In our opinion they should not be used in that
way. However, the central laboratory also needs fur-
ther recommendations.
Addendum
A footnote to table 4 gives the recently improved
data of the ACA Bilirubin Calibrator, which further
confirm that a reference System is needed for both
the commercial and the Professional user.
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